September 17, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Mega Pharmaceutical Astellas Pharma Kicks Off Operations
 

Tokyo, Apr 1, 2005 (JCN) - Astellas Pharma, a new Japanese pharmaceutical giant created through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical, launched its operation on April 1.

Headquartered in Tokyo and staffed with about 17,000 employees, the new company strives to be a global pharmaceutical company originated in Japan focusing on ethical drugs.

Astellas Pharma has implemented the following basic strategies: 1) realize higher capabilities in drug discovery; 2) establish global sales network; 3) develop more efficient organizational and cost structures; 4) proactively pursue business opportunities; 5) implement a capital strategy to improve enterprise value.

The company aims to generate 1 trillion yen ($9.3 bil) in sales of ethical drugs in fiscal 2007, according to its mid-term business plan.

By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Fujisawa Pharmaceutical Company Limited News  
  Mega Pharmaceutical Astellas Pharma Kicks Off Operations  (Apr 1, 2005)
  Fujisawa Pharmaceutical to Outsource Cefzon Bulk Production to API Corporation  (Mar 25, 2005)
  Fujisawa Pharmaceutical to Contract Out Home Healthcare Business to Teijin Pharma  (Mar 7, 2005)
  Fujisawa Pharmaceutical, Carlsson Research Conclude Licensing Agreement for Antipsychotic Agent ACR-16  (Feb 8, 2005)
  Yamanouchi to Spin Off Formulation Plants  (Nov 10, 2004)
  Yamanouchi Pharmaceutical, Fujisawa Pharmaceutical Develop Business Philosphy, Logo, and Corporate Messages for Their Merging Entity Astellas  (Sept 16, 2004)
  Fujisawa Completes Construction of New Formulation Facilities for Micafungin  (Aug 3, 2004)
  Fujisawa and Yamanouchi Will Establish Zepharma Inc., an OTC Pharmaceutical Company  (May 17, 2004)
  Fujisawa Pharmaceutical Revised List of Ethical Drug Products Currently Under Development  (Feb 27, 2004)
  Yamanouchi and Fujisawa to Merge  (Feb 24, 2004)


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)